发明名称
摘要 <p>An ophthalmic solution containing riboflavin and at least a compound chosen in the group composed of essential and conditionally essential amino acids, coenzyme Q, L-proline, glycine, lysine hydrochloride, L-leucine, L-arginine and compounds intended to stimulate the production of metalloproteinase MMP9 for the protection of internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique.</p>
申请公布号 JP2013500302(A) 申请公布日期 2013.01.07
申请号 JP20120522123 申请日期 2010.07.23
申请人 发明人
分类号 A61K31/525;A61K31/122;A61K31/196;A61K31/198;A61K31/352;A61K31/355;A61K31/365;A61K31/401;A61K31/403;A61K31/405;A61K31/407;A61K31/4172;A61K31/42;A61K31/444;A61K31/455;A61K31/5415;A61K31/542;A61K31/60;A61K31/616;A61K31/621;A61K31/63;A61K45/00;A61P27/02 主分类号 A61K31/525
代理机构 代理人
主权项
地址